DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR RIVASTIGMINE
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
All Clinical Trials for Rivastigmine
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00099216 | Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia | Completed | Novartis Pharmaceuticals | Phase 3 | 2001-08-01 | The goal of this research study is to evaluate the effectiveness, tolerability and safety of rivastigmine capsules in males and females between the ages of 50 and 85 years old with probable vascular dementia. |
| NCT00099242 | Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease | Completed | Novartis | Phase 3 | 2003-11-01 | The goal of this research study is to evaluate the safety and efficacy of the rivastigmine transdermal patch in patients with probable Alzheimer's Disease. |
| NCT00102284 | Neuromodulation and Language Acquisition (Project Stage Ia) | Terminated | University Hospital Muenster | Phase 4 | 2004-03-01 | The purpose of this study is to determine whether levodopa, pergolid, rivastigmine, or modafinil are effective in boosting semantic language acquisition in healthy subjects. |
| NCT00102856 | Neuromodulation and Language Acquisition (Stage Ib) | Suspended | University Hospital Muenster | Phase 4 | 2005-01-01 | The purpose of this study is to determine whether rivastigmine or pramipexol are effective in boosting semantic language acquisition in healthy subjects. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Rivastigmine
Condition Name
Condition MeSH
Clinical Trial Locations for Rivastigmine
Trials by Country
Clinical Trial Progress for Rivastigmine
Clinical Trial Phase
Clinical Trial Sponsors for Rivastigmine
Sponsor Name
